Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • News

Overview Of Value Stocks In The Healthcare Sector

By Benzinga Insights
February 12, 10:43 AM
The Meaning Behind Value Stocks A value stock is traditionally defined in terms of how investors in the…

BNTX

Read More
1 minute read
  • News

A Look Into Healthcare Sector Value Stocks

By Benzinga Insights
December 25, 10:43 AM
What Defines a Value Stock? A value stock is traditionally defined in terms of how investors in the…

BNTX

Read More
1 minute read
  • News

Overview Of Value Stocks In The Healthcare Sector

By Benzinga Insights
November 27, 10:43 AM
Understanding Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are…

FWBI

Read More
3 minute read
  • Commodities
  • Earnings
  • Eurozone
  • Global
  • Intraday Update
  • Markets
  • News
  • Penny Stocks
  • Trading Ideas

Nasdaq Jumps 100 Points; US Trade Deficit Widens In September

By Lisa Levin
November 7, 1:05 PM
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 100 points on Tuesday The Dow traded up 0.19% to 34,159.14 while the NASDAQ rose 0.84% to 13,631.99. The S&P 500 also rose, gaining, 0.30% to 4,379.06.

ALTO

Read More
28 minute read
  • Options

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights
September 21, 12:08 PM
  During the session on Thursday, 461 stocks hit new 52-week lows.

$TKO

Read More
1 minute read
  • News

Overview Of Value Stocks In The Healthcare Sector

By Benzinga Insights
June 5, 10:43 AM
What Defines a Value Stock? A value stock traditionally has a lower price when compared to stock prices…

ASRT

Read More
1 minute read
  • Biotech
  • General
  • News

Cigna Is Out With A New Coverage Policy Stating That TherapeuticsMD Imvexxy Is Now Covered. (Effective 1/1/24 But Just Disclosed).

By Happy Mohamed
January 27, 12:27 PM
https://static.cigna.com/assets/chcp/pdf/coveragePolicies/pharmacy/ip_0216_coveragepositioncriteria_vaginal_estrogen_products.pdf

TXMD

Read More
1 minute read
  • Analyst Ratings
  • Initiation
  • News
  • Price Target

Cantor Fitzgerald Reinstates Neutral on TherapeuticsMD, Announces $5 Price Target

By Benzinga Newsdesk
January 11, 8:45 AM
Cantor Fitzgerald analyst Louise Chen reinstates TherapeuticsMD (NASDAQ:TXMD) with a Neutral and announces $5 price target.

TXMD

Read More
2 minute read
  • Movers

12 Health Care Stocks Moving In Monday’s After-Market Session

By Benzinga Insights
January 2, 5:30 PM
Gainers Novo Integrated Sciences (NASDAQ:NVOS) stock rose 44.2% to $0.29 during Monday’s after-market session. At the close, Novo…

ALLR

Read More
2 minute read
  • Movers

12 Health Care Stocks Moving In Monday’s After-Market Session

By Benzinga Insights
December 5, 5:32 PM
Gainers Ambrx Biopharma (NYSE:AMAM) shares increased by 9.3% to $0.57 during Monday’s after-market session. This security traded at…

AMAM

Posts pagination

1 2 … 4 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service